Dr. Alexandra Papaioannou, MD, MSc
Claim this profileMcMaster University - St. Peter's Hospital
Studies Osteoporosis
Studies Motor Skills
5 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Alexandra Papaioannou, MD, MSc is currently running
PREVENT Program
for Hip Fractures
Hip fractures occur nearly twice as often for older adults residing in long-term care as they do in older adults of a similar age still living in other settings. Hip fractures are the leading cause of hospitalization and often result in loss of independence, problems with walking and sometimes death. To address this problem the PREVENT (Person-centered Routine Fracture PrEVENTion in LTC) program was designed for use in long-term care homes. PREVENT uses a tool ("fracture risk calculator") based on a residents electronic health record to capture who is most at risk of fracture due to osteoporosis and falls. The program then trains the health care team including doctors, pharmacists and nurses on the latest recommendations on how to best assist residents and their families in making treatment decisions. The healthcare teams are also given tools that help them stay on track such as templates for ordering medications, strategies to reduce falls and fractures and making care plans. The study will examine if this program is effective for decreasing hip fractures by assigning some homes to receive the PREVENT program (intervention group) and some homes to usual care (control group) and comparing the results.
Recruiting1 award N/A3 criteria
Frailty Rehabilitation
for Older Adults with Frailty
Frailty is an important clinical state that contributes to falls, hospitalization, institutionalization and death. When an individual simultaneously has many health problems, a frailty "tipping point" may be triggered by even a minor stressful event such as adding a new drug or urinary tract infection. Our research suggests that approximately 23% of Canadians over age 65 are frail, and by age 85 this estimate increases to over 40%. As we learn more about frailty and its consequences, there is an urgent need to develop community-based interventions that will prevent or delay frailty in older adults. Our proposed study will examine if frailty rehabilitation program is an effective community-based intervention to promote healthy aging. The primary objective of our study is to determine if 4-month frailty rehabilitation improves physical function compared with control and exercise alone in community-dwelling older adults living with frailty and sarcopenia. Secondary objectives of our study are to determine if 4-months of frailty rehabilitation can improve functional abilities and reduce healthcare utilization during a 6-month follow-up period compared with control and exercise alone. Results will translate the first Canadian model of frailty and sarcopenia rehabilitation and management.
Recruiting1 award N/A6 criteria
More about Alexandra Papaioannou, MD, MSc
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Alexandra Papaioannou, MD, MSc has experience with
- Control
- Group Exercise
- Socialization
- PREVENT Program
- Virtual GERAS DANCE
- Attention Control
Breakdown of trials Alexandra Papaioannou, MD, MSc has run
Osteoporosis
Subtrochanteric Fracture
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexandra Papaioannou, MD, MSc specialize in?
Alexandra Papaioannou, MD, MSc focuses on Osteoporosis and Motor Skills. In particular, much of their work with Osteoporosis has involved treating patients, or patients who are undergoing treatment.
Is Alexandra Papaioannou, MD, MSc currently recruiting for clinical trials?
Yes, Alexandra Papaioannou, MD, MSc is currently recruiting for 2 clinical trials in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Alexandra Papaioannou, MD, MSc has studied deeply?
Yes, Alexandra Papaioannou, MD, MSc has studied treatments such as Control, Group Exercise, Socialization.
What is the best way to schedule an appointment with Alexandra Papaioannou, MD, MSc?
Apply for one of the trials that Alexandra Papaioannou, MD, MSc is conducting.
What is the office address of Alexandra Papaioannou, MD, MSc?
The office of Alexandra Papaioannou, MD, MSc is located at: McMaster University - St. Peter's Hospital, Hamilton, Ontario L8M1W9 Canada. This is the address for their practice at the McMaster University - St. Peter's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.